All filters
Slidesets
The Re-vival of Bile Acid Based Therapeutics for Children and Adults- Saul Karpen
Presented at:
HEP DART 2017
Slidesets
Update on Prophylactic HCV Vaccine Development- Andrea Cox, MD
Presented at:
HEP DART 2017
Slidesets
Hepatitis B virus splice variants are associated with and predictive of Liver cancer- Dr. P. Revill
Presented at:
HEP DART 2017
Slidesets
Seroclearance of HBsAg in Chronic Hepatitis B Virus Patients on Lamivudine, Tenofovir or Entecavir Therapy: A 10 Year Experience- Dr. S. Ono
Presented at:
HEP DART 2017
Slidesets
Lessons learned towards a Vaccine and Functional Cure for HIV (not available)- Mario Stevenson
Presented at:
HEP DART 2017
Slidesets
Liver Directed Acetyl-CoA Carboxylase Inhibitor GS-0976 For NASH (not available)- Adrian Ray
Presented at:
HEP DART 2017
Slidesets
The Effectiveness of Treatment for Chronic Hepatitis C (and Hepatitis B) in Pediatric Populations- Manal El-Sayed, MD, PhD
Presented at:
HEP DART 2017
Slidesets
Aramchol for NASH and beyond: From scientific rationale to clinical development- Carol Brosgart
Presented at:
HEP DART 2017
Slidesets
WHO status report: Global response to the strategic framework- Yvan Hutin, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Real-life experiences - Egypt- Imam Waked, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Setting the stage - Key challenges in elimination- Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
How to measure your success; globally and locally- Yvan Hutin, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Real-life experiences - bottlenecks & hurdles- Myanmar- Khin Pyone Kyi, MBBS, DBact, MMedSc, PhD, FRCP
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Real-life experiences - bottlenecks & hurdles- Brazil- Maria Cássia Jacintho Mendes Correa, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Real-life experiences - bottlenecks & hurdles- Denmark- Jeffrey Lazarus, PhD, MIH, MA
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Real-life experiences - bottlenecks & hurdles- Pakistan- Huma Qureshi, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Real-life experiences - bottlenecks & hurdles- Australia- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Real-life experiences - bottlenecks & hurdles- Nigeria, sub-Saharan Africa- Olufunmilayo Lesi, MD, MBA, FMCP, FWACP
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Prevention transmission strategies prior to infection - People who inject drugs- Diana Sylvestre, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Prevention transmission strategies prior to infection - Incarceration- Lara Strick, MD, MS
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Prevention transmission strategies through strengthening the health system- Maia Butshashvili, MD, MS, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Micro-elimination as a strategy to reach global elimination- Jeffrey Lazarus, PhD, MIH, MA
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017